Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8361956rdf:typepubmed:Citationlld:pubmed
pubmed-article:8361956lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8361956lifeskim:mentionsumls-concept:C0022512lld:lifeskim
pubmed-article:8361956lifeskim:mentionsumls-concept:C0599209lld:lifeskim
pubmed-article:8361956lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:8361956lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:8361956pubmed:issue3lld:pubmed
pubmed-article:8361956pubmed:dateCreated1993-9-27lld:pubmed
pubmed-article:8361956pubmed:abstractTextBecause previous purification procedures for human kappa-casein may have caused the loss of some carbohydrate, relatively gentle methods were used. The protein was isolated by a four-step procedure which included isoelectric precipitation of whole casein, gel chromatography on Sephadex G-200 in the presence of SDS, removal of the SDS with Extracti-Gel D, and FPLC chromatography on Mono Q with buffers containing 6 M urea. The purified protein was nearly identical in amino acid composition to that found earlier by amino acid analysis and peptide sequencing and a molar extinction coefficient of 11.2 +/- 0.1 was determined on the basis of amino acid analysis with a norleucine internal standard. Hydrolysis, acylation, and methylsilylation of the carbohydrate, followed by gas chromatographic analysis on a fused silica column, yielded approximately 5% fucose, 17% galactose, 18% N-acetylglucosamine, 8% N-acetylgalactosamine and 7% sialic acid, totaling almost 55% by weight. The percentages from two different donors were almost the same. About 1 mole phosphorus per mole of kappa-casein was also detected. Using low-speed sedimentation equilibrium methods, a molecular weight of only 33,400 was obtained for human kappa-casein, suggesting carbohydrate lability. Human beta-casein with four phosphoryls was stabilized against precipitation by 10 mM Ca+2 ions at a level greater than 95% when the molar ratio of kappa/beta exceeded 0.15.lld:pubmed
pubmed-article:8361956pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:languageenglld:pubmed
pubmed-article:8361956pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:citationSubsetIMlld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8361956pubmed:statusMEDLINElld:pubmed
pubmed-article:8361956pubmed:monthAuglld:pubmed
pubmed-article:8361956pubmed:issn0032-7484lld:pubmed
pubmed-article:8361956pubmed:authorpubmed-author:SlatteryC WCWlld:pubmed
pubmed-article:8361956pubmed:authorpubmed-author:SoodS MSMlld:pubmed
pubmed-article:8361956pubmed:authorpubmed-author:DevB CBClld:pubmed
pubmed-article:8361956pubmed:authorpubmed-author:DeWindSSlld:pubmed
pubmed-article:8361956pubmed:issnTypePrintlld:pubmed
pubmed-article:8361956pubmed:volume23lld:pubmed
pubmed-article:8361956pubmed:ownerNLMlld:pubmed
pubmed-article:8361956pubmed:authorsCompleteYlld:pubmed
pubmed-article:8361956pubmed:pagination389-407lld:pubmed
pubmed-article:8361956pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:meshHeadingpubmed-meshheading:8361956-...lld:pubmed
pubmed-article:8361956pubmed:year1993lld:pubmed
pubmed-article:8361956pubmed:articleTitleCharacterization of human kappa-casein purified by FPLC.lld:pubmed
pubmed-article:8361956pubmed:affiliationDepartment of Biochemistry, School of Medicine, Loma Linda University, CA 92350.lld:pubmed
pubmed-article:8361956pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8361956pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed